MediMix Respirology
  • Home
  • Congresses
    • 2026
      • ERS 2026
      • EAACI 2026
  • Contact
  • Other specialties
    • Oncology
    • Dermatology
    • Hematology
    • Cardiology
    • Neurology
    • Rheumatology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
    • Logout
ERS 2025 AMSTERDAM

Inhibition of ferroptosis attenuates experimental COPD features

October 24, 2025

Presented by Silke Geirnaert (University Hospital, Ghent, Belgium)

Chronic obstructive pulmonary disease (COPD) is characterized by persistent inflammation and emphysematous destruction of lung tissue, in which cell death plays a central role. In this respect, ferroptosis, an iron-dependent necrotic form of cell death driven by lipid peroxidation, may represent a key pathogenic mechanism in COPD.

Using human lung samples Silke Geirnaert, PhD student at the Ghent University Hospital, assessed specific ferroptosis markers such as glutathione peroxidase-4 (GPX4) and lipid peroxidation. With both these markers significant increases were seen across healthy never-smokers, smokers, and COPD patients, suggesting a progressive role of ferroptosis in disease development.

They subsequently investigated whether ferroptosis inhibition could mitigate experimental COPD phenotypes. In acute models, daily administration of the ferroptosis inhibitor UAMC-3203 during five days of cigarette smoke exposure in C57BL/6 mice significantly reduced bronchoalveolar lavage (BAL) macrophages and the total number of BAL cells. Similarly, in a one-week elastase-induced emphysema model, inhibitor treatment reduced emphysema severity.

In a four-week smoke-exposure model, dose-dependent effects were observed, with higher inhibitor doses progressively reducing the number of neutrophils and dendritic cells. Gene expression analyses confirmed beneficial effects, with significant reductions in MMP-12 and CXCL-1, and upregulation of GPX4.

These findings demonstrate that ferroptosis contributes to both inflammation and tissue destruction in COPD. As such, inhibition of ferroptosis may represent a promising therapeutic strategy in this disease entity.

References:

Geirnaert S, et al. ERS2025; Abstract 2606

Back to ERS 2025

Tags:

poster
MediMix Respirology

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ERS 2026
      • EAACI 2026
  • Contact
  • Other specialties
    • Oncology
    • Dermatology
    • Hematology
    • Cardiology
    • Neurology
    • Rheumatology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.